Non-Chromatographic Antibody Purification Using Aqueous Two-Phase Systems

Thursday, November 12, 2009: 1:10 PM
Delta Ballroom B (Gaylord Opryland Hotel)

Lisong N. Mao, BioPharm Develop, Biogen IDEC, San Diego, CA
Matthew Westoby, BioPharm Develop, Biogen IDEC, San Diego, CA
Andy Koswara, BioPharm Develop, Biogen IDEC, San Diego, CA
Jameson Rogers, BioPharm Develop, Biogen IDEC, San Diego, CA
John Pieracci, BioPharm Develop, Biogen IDEC, San Diego, CA
Lynn Conley, BioPharm Develop, Biogen IDEC, San Diego, CA
Jörg Thömmes, BioPharm Develop, Biogen IDEC, San Diego, CA

The continual drive to increase monoclonal antibody cell culture titers has renewed interest in alternative initial capture steps that can replace traditional protein-A chromatography. One promising area is the use of two-phase aqueous systems composed of two polymers or one polymer and one salt, whose properties drive the selective separation of the target molecule into one of the resultant phases. A two-phase aqueous system comprising a mixture of one polymer – polyethylene glycol (PEG) and one salt – Citrate was investigated for the capture and purification of a monoclonal antibody out of clarified conditioned medium. Parameters affecting antibody partition, impurity clearance and the volume ratio (Vr) of the phases formed were identified using a Design of Experiments methodology, and an operating space was established. A complete partitioning of antibody into the PEG phase was observed with an overall recovery of greater than 80% and a product purity of 99%. Bench-scale experiments laid a solid foundation for future scale-up work.
Extended Abstract: File Not Uploaded
See more of this Session: Downstream Processing: Purification/Polishing
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division